Shares of Gland Pharma fell up to 6% to the day’s low of Rs 1,745 on BSE in Tuesday’s trade after entities related to ex-promoter Dr Ravi Penmetsa likely sold …
Brokerage firm Morgan Stanley maintained an Equal Weight rating on Crompton Greaves Consumer and an overweight rating on Bharat Forge. Jefferies recommended a hold rating on M&M and BofA Securities …
Indian frontline indices S&P BSE Sensex and Nifty50 ended with weekly declines of 2.5% amid the Israel-Hamas conflict, higher bond yields and the ongoing earnings season. Amid a host of …
Mumbai: The next four months could see a massive supply of shares, potentially reaching up to $12 billion from about 40 companies, excluding state-owned firms that went public in the …
Benchmark indices closed lower by around 256 points in a volatile trade on Thursday, snapping its three-day gaining streak. The 30-share BSE Sensex fell 255 points at 64,831, while the …
Indian equities, ahead of the crucial RBI policy outcome on Thursday, ended on a positive note. The Nifty settled at 19,633, up 62 points, while the Sensex added 149 points, …
“If we have to look at a broader structure for Nifty, I believe that 19,800 is a key level which Nifty must cross to give unrelenting confidence to bulls to …
Mumbai: Gland Pharma shares surged 20% Tuesday’s – the highest tradable limit of the day – to over a seven-month high after analysts upgraded their ratings on the stock citing …
Shares of Gland Pharma on Tuesday rallied up to 20% to the day’s high of Rs 1,610 after the company reported better-than-expected June quarter earnings with revenue growing 41% year-on-year …